| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Entrada Therapeutics, Inc. (TRDA) has 7 insiders with recent SEC Form 4 filings, including 16 buys and 19 sells. TRDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.96M | $20.96M | - | |
| 10% | 2.96M | $20.96M | - | |
| CEO | 526.0K | $3.72M | - | |
| 10% | 381.3K | $2.70M | - | |
| Pres | 216.3K | $1.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2022 | Kreher Nerissa54 | Chief Medical Officer | Sale+OE | 2,021 | $15.11 | $30,531.28 | -4.7% | +40.8% | -4.5% | |
| Aug 31, 2022 | Doshi Dipal62 | President And CEO | Sell | 2,000 | $12.72 | $25,435.10 | -0.2% | +11.4% | +16.5% | |
| Aug 25, 2022 | Wentworth Kory James61 | Chief Financial Officer | Sale+OE | 4,669 | $13.78 | $64,361.54 | -11.4% | -2.0% | +7.7% | |
| Aug 23, 2022 | Wentworth Kory James61 | Chief Financial Officer | Sale+OE | 11,655 | $13.08 | $152,432.02 | -20.0% | +9.8% | +25.3% | |
| Aug 18, 2022 | Wentworth Kory James61 | Chief Financial Officer | Sale+OE | 600 | $13.02 | $7,814.00 | -1.0% | +35.2% | +22.1% | |
| Jul 27, 2022 | Doshi Dipal62 | President And CEO | Sell | 2,000 | $12.00 | $24,000.00 | -0.9% | +71.1% | +38.1% | |
| Jun 27, 2022 | Dowden Nathan J70 | Chief Operating Officer | Sell | 7,714 | $13.00 | $100,282.00 | -10.6% | +19.2% | -1.3% | |
| Jun 27, 2022 | Doshi Dipal62 | President And CEO | Sell | 4,000 | $12.00 | $48,000.00 | -1.9% | +19.2% | -1.3% | |
| Jun 6, 2022 | Baker Bros. Advisors LP59 | 10% Owner | Buy | 40,947 | $6.37 | $260,759.62 | +0.3% | +110.3% | +112.1% | |
| May 24, 2022 | Baker Bros. Advisors LP59 | 10% Owner | Buy | 48,509 | $5.82 | $282,447.24 | +0.2% | +118.7% | +112.5% |